Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02CGY
|
||||
Former ID |
DIB007260
|
||||
Drug Name |
Bifemelane
|
||||
Synonyms |
Alnert; Celeport; E-0687; MCI-2016; SON-216
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Terminated | [533445] | ||
Company |
Mitsubishi-Tokyo Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H24ClNO
|
||||
Canonical SMILES |
c1(Cc2ccccc2)c(OCCCCNC)cccc1
|
||||
CAS Number |
CAS 90293-01-9
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Amine oxidase [flavin-containing] A | Target Info | Modulator | [533445] | |
KEGG Pathway | Glycine, serine and threonine metabolism | ||||
Arginine and proline metabolism | |||||
Histidine metabolism | |||||
Tyrosine metabolism | |||||
Phenylalanine metabolism | |||||
Tryptophan metabolism | |||||
Drug metabolism - cytochrome P450 | |||||
Metabolic pathways | |||||
Serotonergic synapse | |||||
Dopaminergic synapse | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Alcoholism | |||||
NetPath Pathway | IL4 Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.